Sutton, United Kingdom

Tatiana Faria Da Fonseca Mchardy



 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tatiana Faria Da Fonseca Mchardy: Innovator in Therapeutic Compounds

Introduction

Tatiana Faria Da Fonseca Mchardy is a prominent inventor based in Sutton, GB. She has made significant contributions to the field of therapeutic compounds, holding a total of three patents. Her work focuses on innovative solutions for treating diseases, particularly those related to cancer.

Latest Patents

One of her latest patents is titled "5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof." This invention pertains to compounds that inhibit Checkpoint Kinase 1 (CHK1) kinase function. The patent outlines the pharmaceutical compositions that include these compounds and their applications in both in vitro and in vivo settings. The compounds are designed to treat various diseases and conditions mediated by CHK1, including proliferative conditions such as cancer. The invention also discusses the potential for combining these compounds with other agents to enhance therapeutic efficacy.

Career Highlights

Tatiana is currently associated with Cancer Research Technology Limited, where she continues her research and development in therapeutic innovations. Her work has been instrumental in advancing the understanding and treatment of cancer through novel compounds.

Collaborations

Tatiana has collaborated with notable colleagues, including Ian James Collins and Thomas Peter Matthews. These partnerships have contributed to her success in the field and the development of impactful therapeutic solutions.

Conclusion

Tatiana Faria Da Fonseca Mchardy is a trailblazer in the realm of therapeutic compounds, with a focus on innovative treatments for cancer. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…